000 01062 a2200277 4500
005 20250516161143.0
264 0 _c20140227
008 201402s 0 0 eng d
022 _a1759-4804
024 7 _a10.1038/nrrheum.2013.113
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHerrero-Beaumont, Gabriel
245 0 0 _aOsteoarthritis: Osteoporotic OA: a reasonable target for bone-acting agents.
_h[electronic resource]
260 _bNature reviews. Rheumatology
_cAug 2013
300 _a448-50 p.
_bdigital
500 _aPublication Type: News; Research Support, Non-U.S. Gov't
650 0 4 _aBone Density Conservation Agents
_xpharmacology
650 0 4 _aBone Remodeling
_xdrug effects
650 0 4 _aDiphosphonates
_xpharmacology
650 0 4 _aHumans
650 0 4 _aOsteoarthritis, Knee
_xdrug therapy
650 0 4 _aOsteoporosis
_xdrug therapy
700 1 _aRoman-Blas, Jorge A
773 0 _tNature reviews. Rheumatology
_gvol. 9
_gno. 8
_gp. 448-50
856 4 0 _uhttps://doi.org/10.1038/nrrheum.2013.113
_zAvailable from publisher's website
999 _c22919854
_d22919854